fep blue glp-1 coverage 2026 for obesity treatment in 13 US states' Medicaid programs Tier exceptions no longer allowed

The latest GLP-1 weight loss drugs are generally approved for chronic weight management in adults with a BMI of 30 or higher and people with a BMI of 27 or higher who also have weight-related conditions like high blood pressure, type 2 diabetes, or high cholesterol

When gastroparesis occurs, the stomach is slow to empty, resulting in persistent symptoms like nausea, vomiting undigested food, abdominal pain, abdominal bloating, severe dehydration, feeling full after only a few bites, undigested food hardening in the stomach, acid reflux, fluctuating blood sugar levels, lack of appetite, weight loss, malnutrition and decreased quality of life

No need to complete the intake to see real numbers

The case raises a question that researchers are now actively investigating

The Pendulum lineup at a glance AFU = Active Fluorescent Units, the live-cell count Pendulum reports via flow cytometry